MODIFICATION OF TUMOR PROMOTION IN THE MOUSE SKIN BY EXPOSURE TO AN ALTERNATING MAGNETIC-FIELD

被引:71
|
作者
STUCHLY, MA
MCLEAN, JRN
BURNETT, R
GODDARD, M
LECUYER, DW
MITCHEL, REJ
机构
[1] HLTH & WELF CANADA, OTTAWA K1A 0L2, ONTARIO, CANADA
[2] ATOM ENERGY CANADA LTD, OTTAWA K1A 0S4, ONTARIO, CANADA
关键词
TUMOR-PROMOTION; MAGNETIC FIELDS; MICE; SKIN;
D O I
10.1016/0304-3835(92)90205-A
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Some epidemiological studies have suggested that exposure to an alternating magnetic field may increase the incidence of some cancers. Our earlier study of carcinogenesis in mouse skin, indicated that exposure to a magnetic field (MF) alone did not promote the growth of tumors. In the present experiment, the ability of a MF to act as a tumor copromoter was investigated. The dorsal skins of female SENCAR mice (6 - 7-weeks-old) were treated with 10 nmol of 7,12-dimethylbenzanthracene (DMBA) to initiate the carcinogenic process and then tumor development was promoted, for 23 weeks, by weekly applications of 4.9 nmol (0.3-mu-g) of 12-0-tetradecanoylphorbal-13-acetate (TPA). One group of 48 mice were exposed to a 60-Hz magnetic field of 2 mT (20 Gauss) for 6 h/day 5 days/week, while a similar group (48 mice) were sham exposed. After week 12, the percentage of mice with tumors and the mean number of tumors per mouse, were higher for the group exposed to MF. At week 18, for example, where the differences between field and sham groups were statistically significant, the percentage of mice with tumors were, respectively, 25 % and 8 % (P < 0. 05, Fisher exact) and, the mean yield of tumors 1.9 +/- 0.69 and 0.65 +/- 0.46 (mean +/- S.E.M.) (P < 0.05, Wilcoxon). At week 23 these differences were no longer statistically significant.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 42 条
  • [1] CANCER PROMOTION IN A MOUSE-SKIN MODEL BY A 60-HZ MAGNETIC-FIELD .2. TUMOR-DEVELOPMENT AND IMMUNE-RESPONSE
    MCLEAN, JRN
    STUCHLY, MA
    MITCHEL, REJ
    WILKINSON, D
    YANG, H
    GODDARD, M
    LECUYER, DW
    SCHUNK, M
    CALLARY, E
    MORRISON, D
    BIOELECTROMAGNETICS, 1991, 12 (05) : 273 - 287
  • [2] CANCER PROMOTION IN A MOUSE-SKIN MODEL BY A 60-HZ MAGNETIC-FIELD .1. EXPERIMENTAL-DESIGN AND EXPOSURE SYSTEM
    STUCHLY, MA
    LECUYER, DW
    MCLEAN, J
    BIOELECTROMAGNETICS, 1991, 12 (05) : 261 - 271
  • [3] INHIBITION OF MOUSE SKIN TUMOR PROMOTION BY TENUAZONIC ACID
    ANTONY, M
    GUPTA, KP
    JANARDANAN, KK
    MEHROTRA, NK
    CANCER LETTERS, 1991, 61 (01) : 21 - 25
  • [4] MOUSE SKIN ORNITHINE DECARBOXYLASE INDUCTION AND TUMOR PROMOTION BY CYCLOHEXANE
    GUPTA, KP
    MEHROTRA, NK
    CANCER LETTERS, 1990, 51 (03) : 227 - 233
  • [5] Inhibitory potency of tacrolimus ointment on skin tumor induction in a mouse model of an initiation-promotion skin tumor
    Mitamura, Takashi
    Doi, Yuko
    Kawabe, Mayumi
    Lilja, Herman
    Motomura, Masatsugu
    Oishi, Yuji
    Yoshizawa, Katsuhiko
    Seki, Jiro
    JOURNAL OF DERMATOLOGY, 2011, 38 (06) : 562 - 570
  • [6] Analyses of magnetic-field peak-exposure summary measures
    Mezei, Gabor
    Bracken, T. Dan
    Senior, Russell
    Kavet, Robert
    JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY, 2006, 16 (06) : 477 - 485
  • [7] Analyses of magnetic-field peak-exposure summary measures
    Gabor Mezei
    T. Dan Bracken
    Russell Senior
    Robert Kavet
    Journal of Exposure Science & Environmental Epidemiology, 2006, 16 : 477 - 485
  • [8] INHIBITION OF MOUSE SKIN TUMOR PROMOTION BY ADRIAMYCIN AND DAUNOMYCIN IN COMBINATION WITH VERAPAMIL OR PALMITOYLCARNITINE
    SATYAMOORTHY, K
    PERCHELLET, JP
    CANCER LETTERS, 1990, 55 (02) : 135 - 142
  • [9] Transforming growth factor β1 enhances tumor promotion in mouse skin carcinogenesis
    Perez-Lorenzo, Rolando
    Markell, Lauren Mordasky
    Hogan, Kelly A.
    Yuspa, Stuart H.
    Glick, Adam B.
    CARCINOGENESIS, 2010, 31 (06) : 1116 - 1123
  • [10] ERBB3 is required for tumor promotion in a mouse model of skin carcinogenesis
    Dahlhoff, Maik
    Schaefer, Matthias
    Muzumdar, Sukalp
    Rose, Christian
    Schneider, Marlon R.
    MOLECULAR ONCOLOGY, 2015, 9 (09) : 1825 - 1833